Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-071910
Filing Date
2025-05-15
Accepted
2025-05-15 06:05:44
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 13089
2 EX-99.1 ck0001669811-ex99_1.pdf EX-99.1 86126
  Complete submission text file 0000950170-25-071910.txt   133687
Mailing Address 444 WEST LAKE STREET 50TH FLOOR CHICAGO IL 60606
Business Address 444 WEST LAKE STREET 50TH FLOOR CHICAGO IL 60606 312.499.2999
BALYASNY ASSET MANAGEMENT L.P. (Filed by) CIK: 0001218710 (see all company filings)

EIN.: 364472709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Subject) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-86603 | Film No.: 25948362
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)